Main content

Nigeria rolls out world鈥檚 first 5-in-1 meningitis vaccine

World first 5-in-1 meningitis vaccine rolled out in Nigeria; How Brazil is coping with long Covid; Using patches of grafted skin to detect donated organ rejection

After a 50% jump in meningitis cases reported across Africa last year, Nigeria is becoming the first country to roll out a new 5-in-1 meningitis vaccine. The Men5CV vaccine protects people against five strains of the meningococcus bacteria.

Claudia Hammond is joined by New Scientist medical journalist Clare Wilson to discuss how it鈥檚 hoped the treatment will help significantly reduce cases of the disease.

We also head to Brazil to hear how the country is dealing with long Covid, four years after the pandemic.

Clare also tells Claudia about the new cancer treatment testing different drugs on thousands of miniature tumours to see which of them works best. The team behind the research at Florida International University in Miami say they hope it could eventually be used routinely for everyone with cancer.

We also get a new update from British journalist Mike Powell, as we follow his journey after receiving a kidney transplant.

And Claudia and Clare look at how patches of skin grafted onto people receiving lung transplants are being used as a way of spotting organ rejection in a new trial.

Image Credit: Martin Harvey

Presenter: Claudia Hammond
Producer: Dan Welsh

Available now

26 minutes

Last on

Sun 21 Apr 2024 01:32GMT

Broadcasts

  • Wed 17 Apr 2024 19:32GMT
  • Thu 18 Apr 2024 04:32GMT
  • Thu 18 Apr 2024 12:32GMT
  • Sat 20 Apr 2024 10:32GMT
  • Sun 21 Apr 2024 01:32GMT

Podcast